66 results about "Glucose meter" patented technology

The invention is embodied in a system for diabetes management including a medical device (MD) and a consumer electronic device (CED). The CED may be used to monitor and/or control the MD. In particular embodiments, the system may include a connector that plugs into the CED to allow communication between the MD and the CED. The medical device may be an external infusion device, implantable pump, glucose meter, glucose monitor, continuous glucose monitoring system, or the like. The CED may be any type of consumer electronic device including, but not limited to, cellular phones, personal digital assistants (PDAs), BlackBerry, Smartphones, pocketpc phones, mp3 players, radios, CD players, and the like.

Method and apparatus for performing a discrete glucose testing and bolus dosage determination including a glucose meter with bolus calculation function are provided.

A glucose meter module integrated into a holster device that can securely accommodate another device such as a portable server device or an insulin pump is described. The glucose measuring module and the health device communicate with each other by a short range wireless modality. In the case in which the accommodated device is a server, such as personal digital assistant or cell phone, the device stores data in a memory, displays data on a visual display, and can wirelessly transmit such data to other devices within a personal area network. In the case where the accommodated device is a cell phone, the phone can further transmit data to remote sites. In the case where the accommodated device is an insulin pump, wirelessly received data are stored in a memory, are available for visual display on the insulin pump, and can be incorporated into the electronic processes that regulate the performance of the pump.

Described and illustrated herein is an exemplary method of operating an analyte measurement device having a display, user interface, processor, memory, and user interface buttons. Such method can be achieved by measuring an analyte with the analyte measurement device, displaying a value representative of the analyte, prompting a user to select a flag to associate the flag with the value, and pressing only one of the user interface buttons once to store the flag with the value in the memory of the analyte measurement device. In one embodiment, the testing device is a glucose meter and the analyte being tested is glucose.

A personal portable painless lancing device and a blood glucose meter using the same, which can lance at the minimum without any pain and use it to measure the blood glucose. The minimum painless lancing device using an Er:YAG laser includes an Er:YAG laser beam-generating section in which the laser beam is generated to punch skin and radiated in a single direction; an adapter installed at the front end of the Er:YAG laser beam-generating section so that the laser beam can be locally concentrated on a skin punch portion; a skin adhesion cap installed at the front end of the adapter so that it can be easily detached, and can reduce the contamination of the Er:YAG laser beam-generating section, which is produced at the time of the lancing, and the danger due to the reuse of it among the patients of lancing; and a case to accommodate the Er:YAG laser beam-generating section and the adapter therein.

The invention relates to a blood glucose detection method based on a glucose meter. The method comprises the following steps: 1) the glucose meter is provided, a control terminal comprises automatic insulin injection equipment, electrocardiogram detection equipment, blood glucose detection equipment and an AVR32 chip, wherein the electrocardiogram detection equipment and the blood glucose detection equipment are used for extracting electrocardiogram data and blood glucose data of a detected person respectively; the AVR32 chip is connected with the automatic insulin injection equipment, the electrocardiogram detection equipment and the blood glucose detection equipment respectively, determines whether to send electrocardiogram parameter alarm signals or not on the basis of the electrocardiogram data and determines a control strategy of the automatic insulin injection equipment on the basis of the blood glucose data; 2), the glucose meter is used. With adoption of the method, an automatic insulin injection mode is adopted to replace the original manual insulin injection mode while whether the electrocardiogram data of the detected person are abnormal or not can be detected automatically, and the medical effect on the detected person is improved.

A method, system and related computer program product for tracking the probability of hypoglycemia from routine self-monitoring of blood glucose (SMBG) data in patients with diabetes. A specific bivariate probability distribution of low BG events based jointly on the Low BG Index (LBGI) and the Average Daily Risk Range (ADRR) is used to predict hypoglycemia probability of occurrence from inputted SMBG data. The SMBG data is retrieved from a series of SMBG data of a patient available from the patient's glucose meter and allows tracking of the probability for future hypoglycemia over a predetermined duration, e.g., a 24 or 48 hour period. The tracking includes presentation of visual and/or numerical output, as we construction of hypoglycemia risk trajectories that would enable warning messages for crossing of predefined thresholds, such as 50% likelihood for upcoming hypoglycemia below 50 mg/dl.

An intelligent microwound blood sugar measurer is composed of test platform; test paper for blood sugar; detecting unit consisting of light source, two optical detectors, two operational amplifiers, and V-F converter; and signal processing unit comprising microcontroller, non-volatile memory, display, communication interface and the optical reflectivity-blood sugar conversion program. Its measuring method is characterized by that the single wavelength is used to measure the reflectivity of reflected intensity to light source intensity and the blood sugar value is found out according to the function LN(C)=ax R+b.

The invention relates to a preparation method of a biosensor for detecting L-histidine and application thereof. Firstly, single strand DNA1 modified by biotin is fixed on magnetic beads (MBs) modified by streptavidin (SA) to obtain a compound DNA1-MBs. In addition, colloidal gold is modified by DNA2 and invertase to obtain DNA2-invertase modified colloidal gold. Then, DNA1-MBs and DNA2-invertase modified colloidal gold are mixed to obtain an L-histidine sensor. A certain amount of L-histidine is added into the prepared L-histidine sensor to react for a period of time, through magnetic separation, a supernatant is obtained, saccharose is added into the supernatant to react for a period of time and is converted to glucose by invertase, generated glucose is directly detected by a glucometer, and the content of L-histidine is detected by detecting the content of glucose. The sensor is high in sensitivity and selectivity; the glucometer is used as a detection instrument and the magnetic beads are used as carriers; the operation is simple; the detection instrument is small in size, low in price and convenient to carry.

The invention relates to a portable medical blood glucose detecting system with a code scanner. The portable medical blood glucose detecting system with the code scanner comprises a portable glucometer with a code scanner, a wireless transmission system, a data management system and a glucometer charging base, wherein the portable medical blood glucose detecting system is interacted with a hospital information system (HIS), a laboratory information system (LIS) and an electronic medical record (EMR) system by virtue of the data management system, so that the functions of two-direction transmission, storage and management of patient information and detection data can be implemented; when the detection begins, the instrument is capable of scanning an identification code on a patient wrist strap and displaying the patient identification information on an instrument screen for checking the identity of the patient by an operator; then the operator collects a micro blood sample of the patient; the blood glucose value of the patient can be detected by the instrument; and the instrument is capable of displaying and storing the patient information and the detection information and transmitting the patient information and the detection information to the data management system by virtue of the wireless transmission system.

The present invention provides a blood glucose measurement method using a blood glucose meter having a step counter function. In the blood glucose measurement method, a blood glucose level is measured in blood glucose measurement mode. The measured blood glucose level is configured in a form of data, the data is stored in a control unit, and the measured blood glucose level is displayed on a display unit under control of the control unit. Current mode is switched to step counting operation mode. The number of steps taken by a user is counted in the step counting operation mode and a count result is displayed on the display unit.

Accordingly, the blood glucose measurement method is advantageous in that the amount of exercise and the blood glucose level can be selectively measured by the blood glucose meter, thus enabling the blood glucose measurement method to be conveniently used.

The invention discloses a blood glucose management-based integrated continuous blood glucose meter. The blood glucose management-based integrated continuous blood glucose meter comprises a blood sampling pen and a test paper needle; a blood sampling needle accommodating portion for accommodating the blood sampling needles is arranged in blood sampling pen, and the blood sampling needles are arranged in the blood sampling needle accommodating portion along a blood sampling pen direction; and a plurality of test paper strips are arranged in the test paper needle along a test paper needle direction. In the above scheme, blood sampling and measurement are designed in an integrated manner, so measurement can be carried out without other devices after blood sampling; and the blood sampling needles and the test paper strips are adopted, so hand-operated replacement after use is not needed, a user can conveniently use the meter, and the measurement waiting time is reduced, thereby the blood glucose measuring accuracy is improved.

Current glucose meters provide instantaneous results however are invasive and painful thus causing reduced compliance. A non-invasive, portable, wearable device would be ideal for monitoring and recording and provide a distinct advantage to current glucose monitors.

The present invention relates to a blood sugar managing watch and a blood sugar managing method. The blood sugar managing watch comprises: a housing having a wrist watch shape; a blood sugar strip connector installed on a side of the housing such that a blood sugar strip is to be connected thereto; and a blood sugar meter that is embedded in the housing and automatically activates a blood sugar measurement task to measure the blood sugar of blood on the blood sugar strip when the blood sugar strip is connected to the blood sugar strip connector.

The invention discloses a detection method for glucose and application of manganese dioxide nanoparticles (MnO<2>NPs) in the aspect of glucose detection. A glucose detection kit comprises a glucose oxidase solution, an alkaline aqueous solution, MnO<2>NPs and a luminol working solution. The detection method for the glucose comprises the steps of 1, mixing a to-be-detected sample with the glucose oxidase solution of which a concentration is 0.8-1.5mg/ml, and carrying out reaction for 6-10min at a temperature of 30-37 degrees centigrade; 2, taking 100mul of reacted solution, and mixing the reacted solution with 100mul of NaOH aqueous solution, 10mul of MnO<2>NPs with the concentration of 0.01-1.0mg.ml<-1> and 50mul of luminol working solution with the concentration of 0.1-10x10<-5>M; and 3,measuring a CL signal and computing glucose concentration according to a regression equation, wherein a linear range is 50muM-15.8mM, a detection limit is 44.7muM, and a detection result is consistentwith a measurement result of a commercial glucose meter well.

Disclosed are a biochip for measuring blood glucose levels and a blood glucose meter for a smartphone including the same. The biochip for measuring blood glucose levels includes: a substrate, one surface of which is provided with a blood glucose inflow region into which blood glucose flows and with a reaction region that is connected to the blood glucose inflow region and has a recess formed therein, a porous separator disposed on the blood glucose inflow region to face the surface of the substrate, and silica nanoparticles and a reaction reagent distributed on the reaction region of the substrate. Thereby, blood glucose levels can be measured using such a biochip, which is easy to carry, together with a CMOS image sensor, and particularly, blood glucose levels can be simply measured using a CMOS image sensor provided to a smartphone, and blood glucose levels can be quantitatively measured and checked using a blood glucose meter application installed on a smartphone.

A blood glucose measurement reagent includes: an enzyme having glucose as a substrate; a mediator; a chromogenic indicator; and an aromatic hydrocarbon having at least one sulfonic acid group. A sensor chip includes: a supply port through which blood is suppliable; a flow path having the supply port formed at one end thereof; and a reagent located in the flow path, the reagent being the blood glucose measurement reagent; wherein the sensor chip is mountable on a blood glucose meter for measuring blood glucose in the blood.

The invention provides a construction method of a type I diabetes animal model. The method comprises the following steps: selecting C57BL/6 mice, performing first tail vein injection, continuously performing intraperitoneal injection of a streptozotocin reagent for 5 days, performing ambrosia for 12 hours before injection, and allowing the mice to freely drink water. Two days after the injection procedure is completed, the ambrosia is carried out for 4 hours, and a glucometer is used for measuring blood glucose until the blood glucose value is 10 mmol/L or above. The statistical analysis of the blood glucose measurement result of the type I diabetes animal model shows that the C57BL/6 mouse type I diabetes model constructed by using the streptozotocin is feasible and can be used for researching the diabetes pathogenesis and the anti-hyperglycemia intervention of medicaments and health-care foods. Compared with the prior art, the C57BL/6 mouse type I diabetes model constructed by the invention has the advantages of high film forming rate, simple operation, no death of animals and good reproducibility.

The invention provides a portable blood glucose meter, which includes a single-chip microcomputer and a blood sugar testing circuit connected to the single-chip microcomputer, a temperature detection circuit, and a digital storage circuit; the blood sugar testing circuit includes an enzyme electrode, an operational amplifier, a resistance-capacitance parallel feedback loop, and an isolation resistor; The blood glucose test circuit collects the blood glucose concentration value and converts it into a current signal, converts the current signal into a voltage signal and amplifies the voltage signal, and the single-chip microcomputer processes the amplified voltage signal to generate a blood glucose value and stores it in the digital storage circuit, The temperature detection circuit is used to supplement the working temperature of the blood glucose testing circuit. The invention can quickly test the blood sugar concentration and ensure the measurement accuracy; meanwhile, it also has a storage function, which is helpful for users to check the historical value and change trend of the blood sugar concentration.